Advanced Non-Clear Cell Renal Cell Carcinoma Treatments and Survival: A Real-World Single-Centre Experience.

Bimbatti, Davide; Pierantoni, Francesco; Lai, Eleonora; Ballestrin, Melissa; Cavasin, Nicolò; Erbetta, Elisa; De Toni, Chiara; Basso, Umberto; Maruzzo, Marco

Bimbatti, Davide; Pierantoni, Francesco; Lai, Eleonora; Ballestrin, Melissa; Cavasin, Nicolò; Erbetta, Elisa; De Toni, Chiara; Basso, Umberto; Maruzzo, Marco.

Afiliação

Bimbatti D; Oncology 1 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.
Pierantoni F; Oncology 3 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.
Lai E; Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padova, Italy.
Ballestrin M; Oncology 1 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.
Cavasin N; Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padova, Italy.
Erbetta E; Oncology 3 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.
De Toni C; Oncology 1 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.
Basso U; Department of Surgery, Oncology and Gastroenterology, University of Padua, 35128 Padova, Italy.
Maruzzo M; Oncology 1 Unit, Istituto Oncologico Veneto, IOV-IRCCS, 35128 Padova, Italy.

Cancers (Basel) ; 15(17)2023 Aug 31.

Article em En | MEDLINE | ID: mdl-37686629

Palavras-chave

immunotherapy combinations; non-clear cell RCC; papillary RCC; renal cell carcinoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Guideline / Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google